In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Patpol’s patent attorneys at Packaging Innovations 2022!

It is already in the coming week when the next edition of Packaging Innovations trade Czytaj dalej

Using a trademark in different form than registered and proofs of genuine use – part 2

The First Board of Appeal of the European Union Intellectual Property Office (EUIPO) presented its Czytaj dalej

Patpol’s experts have been recognized in the WIPR Leaders 2021

We are delighted to announce that Patpol's experts, Izabella Dudek-Urbanowicz, Aleksandra Kryśka and Joanna Piłka Czytaj dalej